Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy

Clinical development of a mesogenic strain of Newcastle disease virus (NDV) as an oncolytic agent for cancer therapy has been hampered by its select agent status due to its pathogenicity in avian species. Using reverse genetics, we have generated a lead candidate oncolytic NDV based on the mesogenic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Principais autores: Cheng, Xing, Wang, Weijia, Xu, Qi, Harper, James, Carroll, Danielle, Galinski, Mark S., Suzich, JoAnn, Jin, Hong
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Genome Replication and Regulation of Viral Gene Expression
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4934751/
https://ncbi.nlm.nih.gov/pubmed/27009956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00136-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados